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ABSTRACT
Objectives: The aim of the study was to evaluate the following: i) number of midwives and nurses at risk for contracting 
varicella; ii) effectiveness of infectious disease prevention among healthcare personnel; iii) attitude of healthcare person-
nel towards immunization. 
Material and methods: A total of 524 midwives and nurses from obstetric, neonatal, and pediatric wards were investigated. 
Quantitative data analysis was performed. 
Results: Overall, 14.7% potentially seronegative respondents were identified. Out of those with a positive history of varicella, 
6.56% contracted the disease after starting work, and > 70% had contact with the varicella-zoster virus. Overall, 9.54% of 
the respondents had a history of varicella, 3.12% were informed about the possibility of immunization, and 1.56% of those 
with a negative history of the disease were offered a state-funded vaccine. In the same group, the number of vaccinated 
people amounted to 13.28%, and 26.13% would accept a state-funded vaccine. 
Conclusions: Varicella may constitute a significant threat to maternal and fetal health at obstetric, neonatal, and pediatric 
wards, which must be considered when providing care to women in the reproductive age. Occupational health physicians 
should confirm the immunity status of the patients and suggest immunization to seronegative subjects. Regular workshops 
are necessary to update the knowledge of medical professionals and patients in order to shape their attitudes and beliefs 
about immunization. 
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INTRODUCTION
Despite great advances in the field of infection control, 
preventive vaccination, and a broad spectrum of preventive 
measures, infectious diseases continue to pose a serious 
threat to healthcare personnel and patients. Healthcare 
professionals with no history of infectious diseases, which 
offers permanent disease immunity, and those who had not 
been vaccinated may be both, at risk for contracting the 
disease and also a source of infection for their seronegative 
patients [1]. 
Varicella
Varicella is a highly contagious, although vaccine-pre-
ventable, disease caused by the varicella-zoster virus (VZV) 
— a member of the α-herpes subfamily. The primary in-
fection causes varicella, whereas reactivation of the latent 
virus leads to the development of herpes zoster. Disease 
presentation in children includes a characteristic rash, with 
high fever, while in adults it may be accompanied by the 
general feeling of fatigue, headaches, and muscle ache. 
The incubation period lasts from 10 to 21 days and patients 
become contagious 1 day before rash onset until the lesions 
have crusted [2]. In Europe, over 90% of children will have 
contracted varicella by the age of 10–12. In Italy and Turkey, 
the rates in the same age group are slightly lower, which 
is probably associated with higher average temperatures 
and different model of childcare [3]. Varicella is frequently 
portrayed as a mild and ‘compulsory’ childhood disease. 
However, cases of severe disease course and even death 
have been reported. Adults, patients with primary or sec-
ondary immunodeficiency, and pregnant women are at 
high risk for severe disease course. Typically, medical his-
tory and the characteristic rash are sufficient to confirm 
varicella, although speedy diagnosis of an acute infection is 
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also possible using PCR amplification of VZV DNA obtained 
from a pustule or the throat. Serological diagnosis of past 
infection is usually performed using ELISA to measure the 
level of specific IgG antibodies against VZV, with the result 
of ≥ 5IU/mL to confirm immunity [4].
Varicella in pregnancy
Varicella during pregnancy is extremely rare and, 
despite being described as a serious infection by most 
obstetric handbooks, complex disease prevention leaves 
much to be desired in many countries. Maternal varicella 
is associated with higher risk for varicella pneumonia with 
a severe course, while fetal risk is associated with con-
genital varicella syndrome (CVS) and neonatal varicella. 
CVS develops in fetuses born to mothers who contracted 
varicella until 28 weeks of gestation. It presents as scarring 
skin lesions, malformations of the lower limbs, defects of 
the central nervous system and eyes, and psychomotor 
retardation. It is connected with a 30% mortality rate in the 
first months of neonatal life and a 15% risk of developing 
herpes zoster between 2 and 41 months of life. Congenital 
varicella is caused by transplacental transmission or the 
neonatal respiratory route after birth. Regardless of the 
fact that varicella-related mortality has lowered over the 
recent years, neonates born < 28 weeks of gestation or 
with birthweight of < 1000 g are at particularly high risk 
for severe disease course. Infection during the perinatal 
period (from 5 days before up to 3 days after birth) poses 
a difficult obstetric-neonatal problem but maternal herpes 
zoster during the perinatal period offers no immediate 
threat, owing to the transplacental mother-to-fetus passive 
transfer of immunity [5].
Prevention
Immunization, recommended by the World Health Or-
ganization (WHO) since the 90s, remains the gold stand-
ard for varicella prevention. Monovalent and multivalent 
(MMR-V) vaccines are currently registered in a one or 
two-dose schedule and contain a live, attenuated VZV. The 
one-dose schedule lowers the mortality rates and the se-
verity of the disease course, whereas the two-dose sched-
ule additionally decreases the incidence and the number 
of disease centers. Seronegative young adults and adults, 
groups at risk for severe course, selected groups with low-
ered immunity and people from their surroundings should 
be vaccinated. WHO emphasizes the importance of medi-
cal history of varicella and immunization of seronegative 
women who plan to conceive. Vaccination during pregnancy 
is not recommended but the literature lacks reports about 
neonates with CVS born to women who were immunized 
during pregnancy. WHO recommends immunization of all 
healthcare workers or at least those who provide care to 
high-risk groups, including neonates born < 28 weeks of 
gestation and with birth weight of < 1000 g [6].
Varicella at hospital wards
Recently, only one account of an infection at an obstetric 
ward has been reported in Poland. Varicella was diagnosed 
in one parturient and forced the hospital management to 
seal the ward and refuse admissions. Due to the lack of ef-
fective screening, three employees whose immunity status 
was unclear were not allowed to work. Additional costs 
were connected with the necessity of using varicella zoster 
immune globulin (VZIG) in four neonates, and the need to 
monitor women and children who had contact with the 
infected woman during hospitalization [7]. Another case, 
avoidable if adequate measures had been applied, took 
place a few years earlier in Australia. A pregnant woman in 
the early phase of varicella spent an hour in the waiting 
room with other gravidas and oncologic patients. As a result, 
105 patients had to be followed, out of them 26 required 
serological testing and 4 had to receive VZIG [8]. The costs of 
varicella infection at an intensive care unit were similar [9]. 
Notably, varicella infection in healthcare centers may be 
associated with severe consequences, financial burden, 
and possible litigation claims from the exposed patients.
OBJECTIVES 
The aim of the study was to evaluate the following: 
i) number of midwives and nurses potentially at risk for 
contracting varicella; ii) effectiveness of medical care as far 
as infectious disease prevention among healthcare person-
nel is concerned; iii) attitude of the healthcare personnel to 
immunization.
MATERIAL AND METHODS
Based on the available literature and our experience, 
an original questionnaire has been designed. It included 
eight close-ended questions about: exposure to varicella (3), 
care and prevention provided by occupational health physi-
cian (3), and decision to undergo immunization (2). Demo-
graphic data were also collected.
The study was conducted between September 1, 
2014 and December 30, 2014 in ten state hospitals from 
the Wielkopolska Region among nurses and midwives who 
have direct contact with women during the perinatal pe-
riod, neonates and infants. Written informed consent was 
obtained. The response rate was 536 out of 580 anonymous 
questionnaires; 524 properly completed questionnaires 
were further processed. 
Respondent characteristics 
Overall, 197 (37.59%) respondents worked at obstetric 
wards which are classified as tertiary, 91 (17.37%) — second-
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ary, and 212 (40.46%) — primary referral centers, whereas 
24 (4.58%) worked at pediatric hospitals. Demographic data 
are presented in Table 1.
RESULTS
Exposure (see: Table 2)
Healthcare (see: Table 3)
Attitude towards immunization among 
respondents with negative varicella history  
(see: Table 4)
DISCUSSION
Based on the analysis, the characteristic of the study 
group, i.e. the fact that over 60% of the respondents 
were > 40, and > 50% had and > 20-yearwork experience, 
constitute an important factor to consider. In other words, 
most respondents completed their education during the 
time when facts about immunization against varicella were 
not included in the school curriculum, and vaccines were 
either not yet introduced or even unavailable in Poland.
Exposure
Analysis of the medical history detected 14.7% of re-
spondents who either never had varicella or had no recollec-
tion of having contracted the disease, thus being potentially 
seronegative, at risk of infection, or a possible source of the 
virus. Importantly, out of the 396 subjects with positive 
history of varicella, 26 (6.56%) contracted the disease after 
starting work. Numerous respondents had contact with VZV 
after starting work: > 30% with varicella, > 25% with varicella 
and herpes zoster, and > 30% with herpes zoster. Taking into 
account a small number of vaccinations in Poland, the prob-
ability of contact with the virus is considerable, especially 
in home environment.
Analysis of the incidence of varicella in Poland presents 
a challenge due to the fact that the member states of the EU, 
Lichtenstein, Norway and Island (EU/EEA) are not obligated 
to monitor these rates, thus lacking a unified system of 
data collection. The passive surveillance model, also applied 
in Poland, may result in underestimation of the incidence 
rates [2].
Between 2010 and 2015, the incidence in Poland ranged 
from 448.67/100 000 in 2011 to 575.9/100 000 in 2014, and 
was high as compared to other countries of the Eastern 
Europe. The incidence ranged from 164/100 000 in Latvia 
Table 1. Characteristics of the study population
Total number  
of the 
respondents
N = 524
Sex Women 97.14% (n = 509)Men 2.86% (n = 15)
Ward
Neonatal — 34.73% (n = 182) 
Pediatric — 13.93% (n = 73) 
Obstetric — 15.8%) (n = 79) 
Delivery — 20.61% (n = 108) 
Pathology of pregnancy — 9.16% (n = 48) 
Age
20–30 — 16.03% (n = 84) 
31–40 — 22.14% (n = 116) 
41–50 — 39.93% (n = 204) 
> 50–22.90% (n = 120)
Work experience 
(in years)
< 10–23.47% (n = 123) 
10–20 — 24.05% (n = 126) 
21-30 — 33.01% (n = 173) 
> 30–19.47% (n = 102)
Education
secondary 41.03% (n = 215)
B.A. 27.67% (n = 145)
M.A. 31.30 % (n = 164)
Table 2. Exposure to varicella among nurses and midwives
History of past infection
Positive Negative Uncertain
Number % Number % Number %
396 75.57 77 14.70 51 9.73
Time of infection
Before starting work After starting work 
Number % Number %
370 93.44 26 6.56
Contact with VZV after starting work
With varicella With herpes zoster With varicella  and herpes zoster Do not remember No contact
Number % Number % Number % Number % Number %
164 31.30 69 13.17 136 25.95 1 0.19 154 29.39
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(mass immunization against varicella) to 481/100 000 in 
Poland (immunization only in selected groups) [10]. The 
WHO-approved herd immunity for varicella occurs when 
91% of the population is immune. In practice, most neonates 
are seropositive due to the antibodies from their seroposi-
tive mothers, which do not guarantee protection from the 
disease. At one year of age, the level of disease immunity 
reaches the lowest values, only to increase later. In Poland, 
studies on immunity against varicella are scarce and were 
conducted only in young populations. Their results have in-
dicated a low level of immunity, e.g. 97.31% among subjects 
aged 18–19, or 95% and 98% among children and teenagers 
(aged 1–19), respectively [11, 12].
A review of the serologic studies on the immunity to vari-
cella in the European countries among various age groups 
confirms the existence of considerable differences. Data 
on immunity to varicella among women are vital from the 
obstetric point of view. Studies in pregnant women revealed 
a relatively high level of immunity (93–99%), but the rate 
was significantly lower in inhabitants of London originally 
from Bangladesh (88%). Research among women in the 
reproductive age from Croatia, Tuscany, and Amsterdam 
found their immunity against varicella to be 84%, 82%, and 
100%, respectively. Women from tropical and subtropical 
countries are more often seronegative [13]. Particularly low 
level of immunity (73.2%) was observed in studies carried 
out in a large group of patients of all ages in Norway. Low 
level of immunity to varicella was detected in all age groups 
for children, while, in comparison, the immunity among 
15–19-year-olds in Poland was 89.5%. A satisfactory level 
of immunity (91.9%) was not found in the age group of 
30–34, and a similar level (> 91%) persisted in older age 
groups [14]. In Israel, mean level of immunity to varicella was 
87.6%, but a statistically significant difference was detected 
between individuals born in (87.7%) and outside (91.7%) 
Israel. The highest level of immunity (97.2%) was noted 
among the Eastern populations (Africa, Asia, Middle East) 
[15]. In light of the immigration waves in Europe, the study 
from Lower Saxony in all immigrants aged > 12, carried 
out between 2014 and 2015, seems particularly valuable. 
Most participants (87.5%) turned out to be seropositive, 
butthe immunity level was statistically significantly differ-
ent between immigrants from various countries (Sudanese 
— only 64%). What is important for the organization of the 
obstetric care, immunity against varicella was different for 
various age groups, with the lowest scores in the group 
of 12–29-year-olds (reproductive age) — 84.9%, and the 
highest among people aged > 45 years — 94.3% [16]. The 
Table 3. Healthcare
History of varicella collected during the first occupational health appointment 
Yes No Do not remember
Number % Number % Number %
50 9.54 166 31.68 308 58.78
Varicella vaccine recommended by an occupational health doctor to patients with negative history of varicella
Yes No Do not remember
Number % Number % Number %
4 3.12 93 72.66 31 24.22
Employer-funded vaccine offered to patients with negative history of varicella
Yes No Do not remember
Number % Number % Number %
2 1.56 103 80.47 23 17.97
Table 4. Attitude towards immunization 
Varicella immunization
Yes No Do not remember
Number % Number % Number %
17 13.28 109 85.16 2 1.56
Willingness to undergo state-funded vaccination (if appropriate)
Yes No Undecided
Number % Number % Number %
29 26.13 36 32.43 46 41.44
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literature offers no studies on the level of immunity among 
healthcare personnel in Poland, although the results of 
several studies from various parts of the world have been 
published. In Asia, disease immunity among healthcare 
personnel varies considerably, e.g. 71% in Iran, 91% in Sin-
gapore, and 95% in Laos [17–19]. In Jordan, mean levels of 
immunity were 92.1% and 92.5% for doctors and nurses, 
respectively [20]. Similarly high level (98.2%) was observed 
for healthcare personnel in Turkey [21]. Despite the lack of 
data from Europe, studies about Belgium and Italy immu-
nity rates revealed high scores as well (98.5% and 97.9%, 
respectively) [22, 23]. Almost all of the above mentioned 
reports emphasize the effect of positive and negative his-
tory of varicella on immunity. Most authors believe that 
negative history does not necessarily signify seronegativity 
but positive history does not guarantee seropositivity. Since 
the levels of detectable antibodies have decreased, more 
sensitive diagnostic tests are needed. 
Care
Only 9.54% of the respondents confirmed, 31.68% de-
nied and 58.78% did not remember whether their varicella 
history was collected during the first occupational health 
appointment. Only 4 people were informed about the 
possibility of immunization, and even fewer were offered 
state-funded vaccination by their employers. Patient age 
also seems to be important — vaccines have been avail-
able in Poland since 2004. In Europe, only 13 countries (but 
not Poland) recommend immunization against varicella to 
seronegative healthcare personnel [2]. Varicella vaccination 
program has been implemented in the USA since 1996, 
which makes it the longest program on record. According 
to the American recommendations, all healthcare person-
nel should have documented immunity against varicella, 
including confirmation of a 2-dose vaccination for varicella 
or laboratory-confirmed immunity, or doctor-confirmed 
history of varicella or herpes zoster [24]. In Poland, the lat-
est recommendations advise an accelerated vaccination 
schedule, which includes obligatory vaccination of people 
at particular risk for the disease, whereas recommended 
vaccination includes children, teenagers, and adults who 
had no history of the disease or varicella immunization, 
children who received only 1 dose of the vaccine with the 
varicella component, who did not have varicella without 
age limitations, and individuals >9 months of life after 
exposure to varicella, up to 72 hours since contact, and 
women who wish to conceive and have no history of vari-
cella infection [25]. 
The vaccination schedule for 2016 was based on the 
above mentioned recommendations but, despite efforts to 
make it more detailed, it also failed to include healthcare 
personnel [26]. Recommendations and standards of pre-
ventive measures in pregnant women include a number of 
recommendations for the pre-conceptual and pregnancy 
care. Regardless, medical history to establish pregnancy 
risk does not include varicella [27, 28]. Employment laws 
concerning medical care also do not mention history of 
varicella, including serological testing and immuniza-
tion of the healthcare personnel [29]. Possible changes 
in the prevention of varicella programs should take into 
account the above mentioned studies on disease immunity 
among the immigrants and recommendations issued by 
the European Centre for Disease Prevention and Control 
in 2015 [30]. 
Attitude to immunization
Analysis of the attitudes to immunization against vari-
cella among patients with negative history of the disease 
has revealed that 13.28% of them were vaccinated — the 
number being relatively high for a country without any so-
cial campaigns supporting immunization. Surprisingly, only 
a small number of the respondents (26.13%) would accept 
state-funded vaccine, and > 70% either oppose immuniza-
tion or have no opinion about that matter. Undoubtedly, 
age and knowledge have both played an important role in 
the decision-making process. Regardless, it seems prudent 
to follow the studies on anti-vaccination movements, at-
titudes to vaccination among patients and personnel, and 
measures which ought to be undertaken to improve the 
situation. Despite successful immunization programs, the 
number of people refusing vaccination remains high. Fear 
of the disease has been replaced with fear of adverse effects, 
which contributes to anti-vaccination movements [31]. 
A review of the literature about the willingness of health-
care personnel to undergo vaccination, emphasized three 
key elements of the decision process: knowledge, attitude, 
and beliefs [32]. In a study from Holland, a small number of 
professionals and patients supported the notion of intro-
ducing mass vaccination schedule against varicella (21% 
and 28%, respectively), but most physicians opted for im-
munization in groups at risk for severe course. Reluctance 
to vaccinate has its roots in the perception of varicella as 
a childhood disease with a mild course [33]. In Holland, 
a study has been conducted about the decision to immunize 
immigrants, the majority of which were willing to vaccinate 
their children. However, they pointed to the existence of 
a language barrier, insufficient amount of information, and 
problems in reaching vaccination centers [34]. Obviously, 
lack of sufficient knowledge about immunization among 
the respondents is the priority concern, and thus studies on 
varicella in pregnancy conducted by French gynecologists 
and obstetricians ought to be mentioned. Their unsatisfac-
tory results seem to confirm the need to constantly update 
the information about vaccines [35]. 
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CONCLUSIONS
Taking into account various arguments in favor of 
changes in varicella prevention in the obstetric care, it is 
important to bear in mind that scientific evidence opposing 
immunization is scarce, whereas the amount of data sup-
porting vaccination is considerable. Varicella may constitute 
a serious threat to maternal, fetal, and neonatal health, and 
there is no possibility of post-exposure immunization of 
pregnant women. Thus, it is vital to focus on women who 
plan to conceive and medical personnel in contact with 
pregnant patients, newborns and infants. All these efforts re-
quire cooperation in the following areas: modification of the 
immunization schedule, occupational medicine care, recom-
mendations for obstetric care, as well as regular trainings for 
professionals and patients to update their knowledge and 
shape their attitudes and beliefs. In the absence of simple 
solutions, it is necessary to establish a dialogue with people 
who oppose immunization, express understanding, get to 
know their arguments and present contra-arguments, but 
most importantly to not leave them without specialist care. 
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